Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SCHLAIFER D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 54 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Couderc, B; Dujols, JP; Mokhtari, F; Norkowski, JL; Slawinski, JC; Schlaifer, D
      The management of adult aggressive non-Hodgkin's lymphomas

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    2. Brousset, P; Krajewski, S; Schlaifer, D; Reed, JC; Delsol, G
      Detection of the cell death-inducing protein BAK in Reed-Sternberg cells of Hodgkin's disease

      LEUKEMIA & LYMPHOMA
    3. Drouet, E; Brousset, P; Fares, F; Icart, J; Verniol, C; Meggetto, F; Schlaifer, D; Desmorat-Coat, H; Rigal-Huguet, F; Niveleau, A; Delsol, G
      High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease

      JOURNAL OF MEDICAL VIROLOGY
    4. Borner, MM; Brousset, P; Pfanner-Meyer, B; Bacchi, M; Vonlanthen, S; Hotz, MA; Altermatt, HJ; Schlaifer, D; Reed, JC; Betticher, DC
      Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 inprimary resected non-small cell lung cancer

      BRITISH JOURNAL OF CANCER
    5. SCHLAIFER D
      LOST POTENTIAL IN FRANCE

      Science
    6. GISSELBRECHT C; SPINA M; GABARRE J; RIZZARDINI G; SCHLAIFER D; NIGRA E; BOUABDALLAH R; SCHRAPPE M; RAPOPORT B; CARBONE C; RAPHAEL M; TIRELLI U
      THERAPY OF HIV-RELATED NON-HODGKINS-LYMPHOMA - AN EUROPEAN MULTICENTRIC RANDOMIZED STUDY IN PATIENTS STRATIFIED ACCORDING TO THEIR PROGNOSTIC FACTORS - PRELIMINARY-RESULTS

      Journal of acquired immune deficiency syndromes and human retrovirology
    7. MONTMAYEUR F; KRAJEWSKI S; BEJUITHIVOLET F; SCHLAIFER D; DELSOL G; REED JC; BROUSSET P
      IN-VIVO PATTERNS OF APOPTOSIS-REGULATING PROTEIN EXPRESSION IN KAPOSIS-SARCOMA

      Applied immunohistochemistry
    8. AURICH J; DASTUGUE N; DUCHAYNE E; SCHLAIFER D; RIGALHUGUET F; CABALLIN MR
      LOCATION OF THE BCR-ABL FUSION GENE ON THE 9Q34 BAND IN 2 CASES OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA

      Genes, chromosomes & cancer
    9. LAURENT G; BETTAIEB A; MANSAT V; LEVADE T; SCHLAIFER D; JAFFREZOU JP
      DRUG-INDUCED DIACYLGLYCEROL PRODUCTION REGULATES INTRACELLULAR CERAMIDE CONCENTRATION, APOPTOSIS AND CYTOTOXICITY

      Blood
    10. MOREL P; MUNCK JN; COIFFIER B; GISSELBRECHT C; LEDERLIN P; LAVAUD A; BOSLY A; TILLY H; QUESNEL B; THYSS A; SCHLAIFER D; BRIERE J; REYES F
      ECVB - A NEW HIGH-DOSE CHOP REGIMEN FOLLOWED BY AN INTENSIVE CONSOLIDATION IN PATIENTS (PTS) AGED LESS-THAN-OR-EQUAL-TO-60 YEARS WITH AGGRESSIVE LYMPHOMA (NHL) PRESENTING WITH ONLY ONE ADVERSE PROGNOSTIC FACTOR OF THE INTERNATIONAL PROGNOSTIC INDEX (IPI) - AN INTERIM ANALYSIS OFTHE LNH93-2 PROTOCOL ON 433 PTS

      Blood
    11. BROUSSET P; ALSAATI T; CHAOUCHE N; ZENOU RC; SCHLAIFER D; CHITTAL S; DELSOL G
      TELOMERASE ACTIVITY IN REACTIVE AND NEOPLASTIC LYMPHOID-TISSUES - INFREQUENT DETECTION OF ACTIVITY IN HODGKINS-DISEASE

      Blood
    12. SCHLAIFER D; KRAJEWSKI S; RIGALHUGUET F; LAURENT G; PRIS J; DELSOL G; REED JC; BROUSSET P
      BCL-X GENE-EXPRESSION IN HODGKINS-DISEASE

      Leukemia & lymphoma
    13. SCHLAIFER D; DUCHAYNE E; DEMUR C; ALVINERIE P; MULLER C; ATTAL M; COOPER MR; PAYEN C; MONSARRAT B; MYERS CE; PRIS J; LAURENT G
      VINCRISTINE DEGRADATION BY SERUM FROM LEUKEMIC PATIENTS - ROLE OF MYELOPEROXIDASE

      Leukemia & lymphoma
    14. ROUSSEAU A; SCHLAIFER D; HUGUET F; CAPDEVILLE J; LEMOZY J; PRIS J
      5 CASES OF AGROBACTERIUM-RADIOBACTER INFE CTION

      Medecine et maladies infectieuses
    15. CAZALSHATEM D; LEPAGE E; BRICE P; FERRANT A; DAGAY MF; BAUMELOU E; BRIERE J; BLANC M; GAULARD P; BIRON P; SCHLAIFER D; DIEBOLD J; AUDOUIN J
      PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 141 CASES COMPARED WITH 916 NONMEDIASTINAL LARGE B-CELL LYMPHOMAS, A GELA (GROUPE-DETUDE-DES-LYMPHOMES-DE-LADULTE) STUDY

      The American journal of surgical pathology
    16. BROUSSET P; SCHLAIFER D; RODA D; MASSIP P; MARCHOU B; DELSOL G
      CHARACTERIZATION OF EPSTEIN-BARR VIRUS-INFECTED CELLS IN BENIGN LYMPHADENOPATHY OF PATIENTS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS

      Human pathology
    17. BRANET F; BROUSSET P; KRAJEWSKI S; SCHLAIFER D; SELVES J; REED JC; CARON P
      EXPRESSION OF THE CELL DEATH-INDUCING GENE BAX IN CARCINOMAS DEVELOPED FROM THE FOLLICULAR CELLS OF THE THYROID-GLAND

      The Journal of clinical endocrinology and metabolism
    18. GALOIN S; ALSAATI T; SCHLAIFER D; HUYNH A; ATTAL M; DELSOL G
      OLIGONUCLEOTIDE CLONOSPECIFIC PROBES DIRECTED AGAINST THE JUNCTIONAL SEQUENCE OF T(14-18) - A NEW TOOL FOR THE ASSESSMENT OF MINIMAL RESIDUAL DISEASE IN FOLLICULAR LYMPHOMAS

      British Journal of Haematology
    19. XERRI L; PARC P; BROUSSET P; SCHLAIFER D; HASSOUN J; REED JC; KRAJEWSKI S; BIRNBAUM D
      PREDOMINANT EXPRESSION OF THE LONG ISOFORM OF BCL-X (BCL-XL) IN HUMANLYMPHOMAS

      British Journal of Haematology
    20. BROUSSET P; BENHARROCH D; KRAJEWSKI S; LAURENT G; MEGGETTO F; RIGALHUGUET F; GOPAS J; PRINSLOO I; PRIS J; DELSOL G; REED JC; SCHLAIFER D
      FREQUENT EXPRESSION OF THE CELL DEATH-INDUCING GENE BAX IN REED-STERNBERG CELLS OF HODGKINS-DISEASE

      Blood
    21. KNECHT H; RAPHAEL M; MCQUAIN C; ROTHENBERGER S; PIHAN G; CAMILLERIBROET S; BACHMANN E; KERSHAW GR; RYAN S; KITTLER ELW; QUESENBERRY PJ; SCHLAIFER D; WODA BA; BROUSSET P
      DELETION VARIANTS WITHIN THE NF-KAPPA-B ACTIVATION DOMAIN OF THE LMP1ONCOGENE PREVAIL IN ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED LARGE-CELL LYMPHOMAS AND HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE ATYPICAL LYMPHOPROLIFERATIONS

      Blood
    22. LAMANT L; MEGGETTO F; ALSAATI T; BRUGIERES L; DEPAILLERETS BB; DASTUGUE N; BERNHEIM A; RUBIE H; TERRIERLACOMBE MJ; ROBERT A; BROUSSET P; RIGAL F; SCHLAIFER D; SHIOTA N; MORI S; DELSOL G
      HIGH-INCIDENCE OF THE T(2-5)(P23-Q35) TRANSLOCATION IN ANAPLASTIC LARGE-CELL LYMPHOMA AND ITS LACK OF DETECTION IN HODGKINS-DISEASE - COMPARISON OF CYTOGENETIC ANALYSIS, REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION, AND P-80 IMMUNOSTAINING

      Blood
    23. SCHLAIFER D; KRAJEWSKI S; GALOIN S; RIGALHUGUET F; LAURENT G; MASSIP P; PRIS J; DELSOL G; REED JC; BROUSSET P
      IMMUNODETECTION OF APOPTOSIS-REGULATING PROTEINS IN LYMPHOMAS FROM PATIENTS WITH AND WITHOUT HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      The American journal of pathology
    24. GABARRE J; LEPAGE E; THYSS A; TUBIANA R; BASTION Y; SCHLAIFER D; SEBBAN C; RIBRAG V; FERERES M; RAPHAEL M; GISSELBRECHT C
      CHEMOTHERAPY COMBINED WITH ZIDOVUDINE AND GM-CSF IN HUMAN IMMUNODEFICIENCY VIRUS-RELATED NON-HODGKINS-LYMPHOMA

      Annals of oncology
    25. BROUSSET P; CHITTAL SM; SCHLAIFER D; DELSOL G
      T-CELL RICH B-CELL LYMPHOMA IN THE LUNG

      Histopathology
    26. BROUSSET P; KRAJEWSKI S; MEGGETTO F; RIGALHUGUET F; LAURENT G; PRIS J; DELSOL G; REED JC; SCHLAIFER D
      FREQUENT EXPRESSION OF THE CELL DEATH-INDUCING GENE BAX IN REED-STERNBERG CELLS OF HODGKINS-DISEASE

      Blood
    27. HAIOUN C; LEPAGE E; GISSELBRECHT C; BASTION Y; DOYEN C; PLANTIER I; SCHLAIFER D; TILLY H; DECONINCK E; BORDESSOULE D; GAULARD P; REYES F
      AUTOLOGOUS TRANSPLANTATION VERSUS CONVENTIONAL SALVAGE THERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PARTIALLY RESPONDING TO FIRST LINECHEMOTHERAPY - A STUDY OF 96 PATIENTS ENROLLED IN THE LNH87-2 PROTOCOL

      Blood
    28. SCHLAIFER D; KRAJEWSKI S; RIGALHUGUET F; MEGGETTO F; PRIS J; MASSIP P; LAURENT G; MARCHOU B; DELSOL G; REED IC; BROUSSET P
      EXPRESSION OF APOPTOSIS-REGULATING GENES IN AIDS-RELATED LYMPHOMAS

      Blood
    29. LAURENT G; BAILLY JD; SKLADANOWSKI A; WIHLELM H; SCHLAIFER D; LARSEN AK
      NATURAL-RESISTANCE OF ACUTE MYELOID-LEUKEMIA TO MITOXANTRONE - ROLE OF DRUG TRANSPORT, TOPOISOMERASE-II ACTIVITY, AND CELL-DEATH PATHWAY

      Blood
    30. KNECHT H; RAPHAEL M; MCQUAIN C; ROTHENBERGER S; PIHAN G; BACHMANN E; RYAN S; KITTLER ELW; QUESENBERRY PJ; SCHLAIFER D; WODA BA; BROUSSET P
      DELETION VARIANTS WITHIN THE NF-KAPPA-B ACTIVATION DOMAIN OF THE LMPIONCOGENE OF EPSTEIN-BARR-VIRUS PREVAIL IN AIDS-RELATED LARGE-CELL - LYMPHOMAS AND HIV-NEGATIVE ATYPICAL LYMPHOPROLIFERATIONS

      Blood
    31. SCHLAIFER D; MARCH M; KRAJEWSKI S; LAURENT G; PRIS J; DELSOL G; REED JC; BROUSSET P
      HIGH EXPRESSION OF THE BCL-X GENE IN REED-STERNBERG CELLS OF HODGKINS-DISEASE

      Blood
    32. FRAGA M; BROUSSET P; SCHLAIFER D; PAYEN C; ROBERT A; RUBIE H; HUGUETRIGAL F; DELSOL G
      BONE-MARROW INVOLVEMENT IN ANAPLASTIC LARGE-CELL LYMPHOMA - IMMUNOHISTOCHEMICAL DETECTION OF MINIMAL DISEASE AND ITS PROGNOSTIC-SIGNIFICANCE

      American journal of clinical pathology
    33. SCHLAIFER D; DASTUGUE N; BROUSSET P; DELSOL G; MULLER C; RIGALHUGUET F; ATTAL M; LAURENT G; PRIS J
      B-CELL LYMPHOMA FOLLOWING POLYCYTHEMIA-VERA - EVIDENCE FOR THE INVOLVEMENT OF 2 DIFFERENT CLONES

      Leukemia
    34. SCHLAIFER D; COOPER MR; ATTAL M; ROUSSEAU A; PRIS J; LAURENT G; MYERS CE
      POTENTIAL STRATEGIES FOR CIRCUMVENTING MYELOPEROXIDASE-CATALYZED DEGRADATION OF VINCA ALKALOIDS

      Leukemia
    35. SCHLAIFER D; MEYER K; MULLER C; ATTAL M; SMITH MT; TAMAKI S; WEIMELS J; PRIS J; JAFFREZOU JP; LAURENT G; MYERS CE
      ANTISENSE INHIBITION OF MYELOPEROXIDASE INCREASES THE SENSITIVITY OF THE HL-60 CELL-LINE TO VINCRISTINE

      Leukemia
    36. ATTAL M; CANAL P; SCHLAIFER D; CHATELUT E; DEZEUZE A; HUGUET F; PAYEN C; PRIS J; LAURENT G
      ESCALATING DOSE OF MITOXANTRONE WITH HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE IN PATIENTS WITH REFRACTORY LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Journal of clinical oncology
    37. SCHLAIFER D; DUMAZER P; SPENATTO N; MIGNONCONTE M; BROUSSET P; LUMBROSO C; COOPER M; MULLER C; HUGUET F; ATTAL M; LAURENT G; PRIS J
      HEMOLYTIC-UREMIC SYNDROME IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH INTERFERON-ALPHA

      American journal of hematology
    38. SCHLAIFER D; BROUSSET P; ATTAL M; MASSIP P; PAYEN C; MARCHOU B; HUGUET F; MULLER C; LAURENT G; PRIS J; DELSOL G
      BCL-2 PROTOONCOGENE AND EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 EXPRESSION IN AIDS-RELATED LYMPHOMA

      Histopathology
    39. BROUSSET P; DROUET E; SCHLAIFER D; ICART J; PAYEN C; MEGGETTO F; MARCHOU B; MASSIP P; DELSOL G
      EPSTEIN-BARR-VIRUS (EBV) REPLICATIVE GENE-EXPRESSION IN TUMOR-CELLS OF AIDS-RELATED NON-HODGKINS-LYMPHOMA IN RELATION TO CD4 CELL NUMBER AND ANTIBODY-TITERS TO EBV

      AIDS
    40. SCHLAIFER D; ATTAL M; HUGUET F; CANAL P; LAURENT G; PRIS J
      ESCALATING DOSE OF MITOXANTRONE WITH HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE IN REFRACTORY LYMPHOMA PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Seminars in hematology
    41. SCHLAIFER D; RIGALHUGUET F; PRIS J; BROUSSET P; DELANNOY A; BOSLY A
      SECONDARY NEOPLASMS IN 2 PATIENTS TREATED WITH PURINE ANALOGS

      Nouvelle revue francaise d'hematologie
    42. ATTAL M; CANAL P; SCHLAIFER D; PRIS J; LAURENT G
      SIGNIFICANCE OF HIGH-DOSAGE MITOXANTRONE IN MANAGEMENT OF MALIGNANT-LYMPHOMAS

      Nouvelle revue francaise d'hematologie
    43. SCHLAIFER D; SIORAT F
      A LINE IN THE SEA

      Nature
    44. SCHLAIFER D; RIGALHUGUET F; ROBERT A; ATTAL M; ABBAL M; FONCK Y; LAURENT G; PRIS J; DELSOL G; BROUSSET P
      EPSTEIN-BARR-VIRUS IN FAMILIAL HODGKINS-DISEASE

      British Journal of Haematology
    45. BROUSSET P; SCHLAIFER D; MEGGETTO F; BACHMANN E; ROTHENBERGER S; PRIS J; DELSOL G; KNECHT H
      PERSISTENCE OF THE SAME VIRAL STRAIN IN EARLY AND LATE RELAPSES OF EPSTEIN-BARR VIRUS-ASSOCIATED HODGKINS-DISEASE

      Blood
    46. HUYNH A; HUGUET F; PAYEN C; SCHLAIFER D; MULLER C; DEMUR C; BLOOM D; PRIS J; HAROUSSEAU JL; ATTAL M
      COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS, MOBILIZED WITH G-CSF IN MULTIPLE-MYELOMA

      Blood
    47. MULLER C; MEGETTO F; FILLOLA G; ATTAL M; RIGALHUGUET F; SCHLAIFER D; HUYNH A; LAURENT G; PRIS J; CORBERAND J; DELSOL G
      DAUNORUBICIN ACCUMULATION AND RETENTION IN FRESH HUMAN MYELOMA CELLS - ABSENCE OF CORRELATION WITH P-GLYCOPROTEIN EXPRESSION

      Blood
    48. ATTAL M; HUYNH A; SCHLAIFER D; MULLER C; HUGUET F; PAYEN C; PRIS J
      INTENSIVE COMBINED THERAPY FOR PREVIOUSLY UNTREATED AGGRESSIVE MYELOMA - LONG-TERM FOLLOW-UP

      Blood
    49. DEMUR C; SCHLAIFER D; BOUSQUET C; MULLER C; SIE P; MYERS CE
      POTENT CYTOTOXIC EFFECT OF GERANYL GERANOL (GG) AGAINST ACUTE MYELOID-LEUKEMIA (AML) CELLS

      Blood
    50. SCHLAIFER D; RIGALHUGUET F; ROBERT A; ATTAL M; ABBAL M; FONCK Y; MULLER C; HUYN A; LAURENT G; PRIS J; DELSOL G; BROUSSET P
      EPSTEIN-BARR-VIRUS IN FAMILIAL HODGKINS-DISEASE

      Blood
    51. GIRAUD P; ATTAL M; LEMOUZY J; HUGUET F; SCHLAIFER D; PRIS J
      LEUCONOSTOC, A POTENTIAL PATHOGEN IN BONE-MARROW TRANSPLANTATION

      Lancet
    52. CANAL P; ATTAL M; CHATELUT E; GUICHARD S; HUGUET F; MULLER C; SCHLAIFER D; LAURENT G; HOUIN G; BUGAT R
      PLASMA AND CELLULAR PHARMACOKINETICS OF MITOXANTRONE IN HIGH-DOSE CHEMOTHERAPEUTIC REGIMEN FOR REFRACTORY LYMPHOMAS

      Cancer research
    53. ATTAL M; HUGUET F; RUBIE H; CHARLET JP; SCHLAIFER D; HUYNH A; LAURENT G; PRIS J
      PREVENTION OF REGIMEN-RELATED TOXICITIES AFTER BONE-MARROW TRANSPLANTATION BY PENTOXIFYLLINE - A PROSPECTIVE, RANDOMIZED TRIAL

      Blood
    54. SCHLAIFER D; BROUSSET P; ATTAL M; MASSIP P; PAYEN C; HUGUET F; MULLER C; LAURENT G; PRIS J; DELSOL G
      IMMUNOHISTOCHEMICAL DETECTION OF BCL-2 AND EBSTEIN-BARR VIRUS LATENT MEMBRANE PROTEIN-1 IN AIDS-RELATED LYMPHOMA

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 00:41:04